Later, Breen et al. (2012) demonstrated increased complement activation in APS patients, identifying higher levels of Bb and C3a-desArg, which were notably elevated in patients with high-risk aPL [58]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.